Want to join the conversation?
In 2015, $KMB returned $2.1Bil to shareholders through share repurchases and dividends. In 2016, $KMB plans to repurchase between $600-900MM of stock. $KMB expects organic sales growth of 3-5% for 2016. $KMB expects currency translation to reduce sales and earnings by 5-6% in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.